A short cut review was carried out to establish whether peripheral metaraminol infusions can be safely and effectively used in emergency department patients. 239 papers were found of which 8 presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. The clinical bottom line is that despite anecdotal evidence of common usage there is limited high quality evidence to support the use of peripheral metaraminol as vasopressor support in the emergency department.
ThrEE-parT quEsTion
In (adult patients presenting to the ED with sepsis resulting in persistent hypotension not responding to fluid replacement) is a (peripheral metaraminol infusion as effective as central catecholamine infusion) for (maintaining a blood pressure capable of effective organ perfusion)?
CliniCal sCEnario
A previously fit and well 36-year-old male returns from a holiday to Greece 48 hours ago and presents to the ED complaining of headache, malaise and feeling generally unwell. While waiting to be seen, the patient's headache rapidly worsens, he spikes a high temperature of 38.9°C, becomes increasingly agitated and starts vomiting. He is taken to a resuscitation cubicle and has a HR of 135 bpm and BP of 71/45 mm Hg. Examination of the patient reveals several small non-blanching petechiae. You manage the patient as suspected meningitis and commence appropriate sepsis management. After administrating 3 L of intravenous fluid, the patient remains with a systolic BP <80 mm Hg. The intensive care doctor informs you that they are trying to make a space available in the intensive treatment unit for this patient but are struggling to step anyone down and the patient must remain in the resuscitation department. The resuscitation nurse asks you to prescribe more fluid. You wonder whether a peripheral metaraminol infusion would be more effective at increasing arterial pressure and maintaining organ perfusion. Citations from articles of interest were also searched and revealed several new articles which appeared relevant to the three-part question. However, these were all predated publications from 1964. For most articles, I was unable to obtain an abstract, the abstract was in a foreign language and I was unable to obtain any articles in full via internet or library searches.
In total, eight articles were identified that were relevant to the three-part question (table 3) .
CommEnTs
Natalini et al specifically focused on the comparison of noradrenaline and metaraminol as a vasopressor for the management of septic shock and revealed that there was no significant difference in patient's cardiac output, haemodynamic variables or acid-base status. They also found that there was no relationship in the doses provided to achieve patient optimisation. Hou et al demonstrated that metaraminol infusion caused no statistical difference to renal function over time regardless of the infusion strength. Makowski et al conducted a small study which demonstrated that metaraminol can be given to good effect peripherally and potentially be used for long periods of time. The remaining studies demonstrated that metaraminol was an effective treatment for managing shock when compared with other vasopressor therapies, both in terms of drug efficacy and patient mortality. All of the studies were small retrospective or prospective cohort studies, with one small crossover trial, at which the level of evidence was not very strong. One of the studies was identified as a poster presentation at an International anaesthetic conference had only ever been published in abstract form, making appraisal of the study findings impossible. All the papers had low numbers of patients, there were no MAP, mean arterial pressure.
Table 3
Continued randomised trials and the outcomes were not always clear. Several of the publications were written in an unorthodox format which is likely a reflection of the period from which they were published, making appraisal of the data very difficult and applicability to modern medicine practice questionable. None of the papers used blinding or randomisation techniques, and only Natalini et al set out a detailed inclusion criteria to attempt to reduce confounding factors. Several of the selected papers were published over 50 years ago, making them no longer generalisable among modern medicine practice, while the Chinese patient group from Hou et al may not be reflective of a typical UK patient demographic. Anecdotally, we know that peripheral metaraminol is used in UK practice and has many advocates, but this should arguably be tested in a randomised controlled trial with adult patients to compare peripheral metaraminol against alternative circulatory support strategies.
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